Geratherm Medical AG
Geratherm Medical AG operates as a medical technology company in Germany. It operates through Healthcare Diagnostic, Respiratory, Cardio/Stroke, and Medical Warming Systems segments. The Healthcare Diagnostic segment provides clinical thermometers; and blood pressure monitors. The Respiratory segment develops and manufactures products primarily for pulmonary and cardiopulmonary function diagnosti… Read more
Market Cap & Net Worth: Geratherm Medical AG (GME)
Geratherm Medical AG (XETRA:GME) has a market capitalization of $15.67 Million (€15.26 Million) as of March 19, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #31762 globally and #3528 in its home market, demonstrating a 1.08% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Geratherm Medical AG's stock price €2.82 by its total outstanding shares 5411945 (5.41 Million).
Geratherm Medical AG Market Cap History: 2015 to 2026
Geratherm Medical AG's market capitalization history from 2015 to 2026. Data shows change from $44.35 Million to $15.67 Million (-9.51% CAGR).
Geratherm Medical AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Geratherm Medical AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.95x
Geratherm Medical AG's market cap is 0.95 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
27.41x
Geratherm Medical AG's market cap is 27.41 times its annual earnings
1.95x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $44.35 Million | $21.59 Million | $2.70 Million | 2.05x | 16.42x |
| 2016 | $49.82 Million | $22.06 Million | $2.24 Million | 2.26x | 22.27x |
| 2017 | $53.24 Million | $21.03 Million | $679.79K | 2.53x | 78.32x |
| 2018 | $40.57 Million | $21.52 Million | $1.15 Million | 1.89x | 35.17x |
| 2019 | $40.64 Million | $19.85 Million | $289.86K | 2.05x | 140.22x |
| 2020 | $54.76 Million | $27.47 Million | $2.05 Million | 1.99x | 26.78x |
| 2021 | $43.64 Million | $24.64 Million | $122.23K | 1.77x | 357.03x |
| 2022 | $26.42 Million | $25.85 Million | $1.02 Million | 1.02x | 25.81x |
| 2023 | $29.23 Million | $20.96 Million | $1.11 Million | 1.39x | 26.31x |
| 2024 | $19.33 Million | $20.43 Million | $705.17K | 0.95x | 27.41x |
Competitor Companies of GME by Market Capitalization
Companies near Geratherm Medical AG in the global market cap rankings as of March 19, 2026.
Key companies related to Geratherm Medical AG by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Geratherm Medical AG Historical Marketcap From 2015 to 2026
Between 2015 and today, Geratherm Medical AG's market cap moved from $44.35 Million to $ 15.67 Million, with a yearly change of -9.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €15.67 Million | -2.42% |
| 2025 | €16.05 Million | -16.95% |
| 2024 | €19.33 Million | -33.87% |
| 2023 | €29.23 Million | +10.66% |
| 2022 | €26.42 Million | -39.47% |
| 2021 | €43.64 Million | -20.31% |
| 2020 | €54.76 Million | +34.74% |
| 2019 | €40.64 Million | +0.18% |
| 2018 | €40.57 Million | -23.80% |
| 2017 | €53.24 Million | +6.88% |
| 2016 | €49.82 Million | +12.34% |
| 2015 | €44.35 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Geratherm Medical AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $15.67 Million USD |
| MoneyControl | $15.67 Million USD |
| MarketWatch | $15.67 Million USD |
| marketcap.company | $15.67 Million USD |
| Reuters | $15.67 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.